Salvage high-dose-rate brachytherapy for local prostate cancer recurrence after radiotherapy - Preliminary results

BJU International

Volumn 109, Issue 6, 2012, Pages 835-839

  Jo, Yoshimasa ^a   Fujii, Tomohiro ^a   Hara, Ryoei ^a   Yokoyama, Teruhiko ^a   Miyaji, Yoshiyuki ^a   Yoden, Eisaku ^b   Hiratsuka, Junichi ^b   Nagai, Atsushi ^a  

^a Kurashiki Medical School Urology   (Japan)

^b KAWASAKI MEDICAL SCHOOL   (Japan)

Author keywords

brachytherapy; high dose rate; iridium 192 (Ir 192); prostate cancer; salvage therapy

Indexed keywords

HORMONE; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER HORMONE THERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; ELECTRON THERAPY; HUMAN; MALE; MINIMAL RESIDUAL DISEASE; OUTCOME ASSESSMENT; POLLAKISURIA; PRIORITY JOURNAL; PROSTATE CANCER; PROTON THERAPY; RADIATION DOSE; RADIATION INJURY; RADIATION RESPONSE; RECURRENT CANCER; SALVAGE THERAPY; TREATMENT DURATION;

AGED; AGED, 80 AND OVER; BRACHYTHERAPY; FOLLOW-UP STUDIES; HUMANS; IRIDIUM RADIOISOTOPES; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROSTATIC NEOPLASMS; RADIOTHERAPY DOSAGE; SALVAGE THERAPY; TREATMENT OUTCOME;

EID: 84857655164     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2011.10519.x     Document Type: Article

References (19)

1. D'Amico AV, Whittington R, Malkowiez SB, et al,. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA 1998; 16: 969-74 (Pubitemid 28445094)
2. Valicenti R, Lu J, Pilepich M, et al,. Survival advantage from higher-dose radiation therapy for clinically localized prostate cancer treated on the Radiation Therapy Oncology Group trials. J Clin Oncol 2000; 18: 2740-6 (Pubitemid 30463557)
3. Kupelian PA, Potters L, Khuntia D, et al,. Radical prostatectomy, external radiotherapy 72Gy, external beam radiotherapy(> or = 72Gy, permanent seed implantation, or combined seed/external beam radiotherapy for stage T1-T2 prostate cancer. Int J Radiat Oncol Biol Phys 2004; 58: 25-33 (Pubitemid 38010333)
4. Tsushima T, Nasu Y, Saika T, et al,. Optimal starting time for flutamide to prevent disease flare in prostate cancer patients treated with a gonadotropin-releasing hormone agonist. Urol Int 2001; 66: 135-9 (Pubitemid 32375202)
5. Akaza H, Usami M, Hinotsu S, et al,. Characteristics of patients with prostate cancer who have initially been treated by hormone therapy in Japan: J-Cap surveillance. Jpn J Clin Oncol 2004; 34: 329-36 (Pubitemid 43115314)
6. Diamond TH, Higano CS, Smith MR, et al,. Osteoporosis in men with prostate carcinoma receiving androgen-deprivation therapy: recommendations for diagnosis and therapies. Cancer 2004; 100: 892-9 (Pubitemid 38222847)
7. Chin JL, Pautler SE, Mouraviev V, et al,. Results of salvage cryoablation of the prostate after radiation: identifying predictors of treatment failure and complications. J Urol 2001; 165: 1937-42
8. Beyer DC,. Permanent brachytherapy as salvage treatment for recurrent prostate cancer. Urology 1999; 54: 880-3 (Pubitemid 29505590)
9. Lee B, Shinohara K, Weinberg V, et al,. Feasibility of high-dose-rate brachytherapy salvage for local prostate cancer recurrence after radiotherapy: the University of California-San Francisco experience. Int J Radiat Oncol Biol Phys 2007; 67: 1106-12
10. Hiratsuka J, Jo Y, Yoshida K, Nagase N, Fujisawa M, Imajo Y,. Clinical results of combined treatment conformal high-dose-rate iridium-192 brachytherapy and external beam radiotherapy using staging lymphadenectomy for localized prostate cancer. Int J Radiat Oncol Biol Phys 2004; 59: 684-90 (Pubitemid 38748733)
11. Jo Y, Hiratsuka J, Fujii T, Takenaka A, Imajo Y, Fujisawa M,. High-dose-rate iridium-192 afterloading therapy combined with external beam radiotherapy for T1c-T3bN0M0 prostate cancer. Urology 2004; 64: 556-60 (Pubitemid 39200757)
12. Tharp M, Hardacre M, Bennett R, Jones WT, Stuhldreher D, Vaught J,. Prostate high-dose-rate brachytherapy as salvage treatment of local failure after previous external or permanent seed irradiation for prostate cancer. Brachytherapy 2008; 7: 231-6
13. Koutrouvelis P, Hendricks F, Lailas N, et al,. Salvage reimplantation in patient with local recurrent prostate carcinoma after brachytherapy with three dimensional computed tomography-guided permanent pararectal implant. Technol Cancer Res Treat 2003; 2: 339-44 (Pubitemid 37022351)
14. Grado GL, Collins JM, Kriegshauser JS, et al,. Salvage brachytherapy for localized prostate cancer after radiotherapy failure. Urology 1999; 53: 2-10 (Pubitemid 29016606)
15. Losa A, Nava LD, Muzio ND, et al,. Salvage brachytherapy for local recurrence after radical prostatectomy and subsequent external beam radiotherapy. Urology 2003; 62: 1068-72 (Pubitemid 37510093)
16. Lee WR, Hanks GE, Hanlon A,. Increasing prostate-specific antigen profile following definitive radiation therapy for localized prostate cancer: clinical observations. J Clin Oncol 1997; 15: 230-8 (Pubitemid 27020578)
17. D'Amico AV,. Analysis of the clinical utility of the use of salvage brachytherapy in patients who have a rising PSA after definitive external beam radiation therapy. Urology 1999; 54: 201-3 (Pubitemid 29367237)
18. Beyer DC,. Salvage brachytherapy after external-beam irradiation for prostate cancer. Oncology 2004; 18: 151-8
19. Moman MR, van den Berg CA, Boeken Kruger AE, et al,. Focal salvage guided by T2-weighted and dynamic contrast-enhanced magnetic resonance imaging for prostate cancer recurrences. Int J Radiat Oncol Biol Phys 2010; 76: 741-6